SURVYR

CDRE

Cadre Holdings Inc.
$30.64
+$0.01 (0.03%)Oct 27 close
Defense & SafetySP500 CompareTechnicals
Model valuationLeans expensiveDCF base $35
1M3M6M1Y2Y
-42%-28%-14%+1%+15%Oct 2025Oct 2026Apr 202652w high $45.7652w low $24.55
CDRESPY
Wall St. Highest PT $58.07 (+89.5%) Wall St. Avg PT $47.60 (+55.4%)
$25$38$51$65$78POC $30Hi $58Avg $48
Underwater Drawdown %Max DD -46.4%Current -33.0%
0.0%-46.4%
Relative Strength vs SPY-41.3% vs SPYUnderperforming
+66%0%-66%
1W
+$3.59 (13.27%)
1M
+$4.25 (16.10%)
3M
−$2.65 (7.96%)
6M
+$1.13 (3.82%)
YTD
−$9.83 (24.29%)
1Y
−$11.78 (27.78%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street & Morningstar coverage
Wall Street consensusNo covering analysts on file for CDRE
Analyst price targetsNo target range on file
Morningstar star ratingNot rated
Checked Wall Street & Morningstar feeds · All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Health check

Quality
WeakAverageStrong
Average
Piotroski F-score 6 of 9
See the tests
  • ✓Positive net income
  • ✓Positive operating cash flow
  • ✓Return on assets improved
  • ✓Cash flow above net income
  • ✗Long-term debt / assets fell
  • ✓Current ratio improved
  • ✗No share dilution
  • ✓Gross margin improved
  • ✗Asset turnover improved

Computed by SURVYR. from the company's SEC filings (latest balance sheet Jun 30, 2026). Descriptive, not a forecast.

Key stats & company

52-week range$24.55 – $45.76

What they do

Cadre Holdings, Inc. manufactures and distributes safety equipment and other related products that provides protection to users in hazardous or life-threatening situations in the United States and internationally. It operates through two segments, Product and Distribution. The company offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names.

Industrials · Aerospace & Defense
Valuation and fundamentals

Valuation & fundamentals

Bottom line
Leans expensive
Model read-out from the numbers below, not advice. Score -1 (DCF counts double).
•DCF (base case)above the price by 13%
•Piotroski F-score6/9
▼Net debt / EBITDA3.5x

Discounted cash flow

Bear
$19
-37%
growth 5% · disc. 10.2% · term. 2.0%
Base
$35
+13%
growth 10% · disc. 9.2% · term. 2.5%
Bull
$56
+84%
growth 13% · disc. 8.2% · term. 3.0%

A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.

Reverse DCFfor context, not a signal
Not enough data to run a reverse DCF.
Edit assumptions · recalculates instantly
Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.00 (n/a) × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs Defense & Safety

P/E (trailing)
sector median –
 –
Forward P/E
sector median –
 –
EV / EBITDA
sector median –
 –
Price / sales
sector median –
 –
Price / book
sector median –
 –
FCF yield
sector median –
 –

Backlog (remaining performance obligations)

RPO
$184.9M
as of 2026-06-30
vs a year ago
+161%
YoY
× TTM revenue
0.27×
coverage
24-09
24-12
25-03
25-06
25-09
25-12
26-03
26-06

Contracted revenue not yet recognized, from SEC filings (XBRL tag RevenueRemainingPerformanceObligation).

Quality & financial health

Gross margin
41.8%
Operating margin
10.1%
FCF margin
11.4%
Net margin
5.3%
Return on equity
10.4%
Return on invested capital
7.1%
Net debt / EBITDA
3.5×
Current ratio
2.1×
Interest cover
6.9×
Cash conversion (OCF/NI)
2.5×
Piotroski F-score 6/9 · last two fiscal years
✓ Positive net income✓ Positive operating cash flow✓ Return on assets improved✓ Cash flow above net income✗ Long-term debt / assets fell✓ Current ratio improved✗ No share dilution✓ Gross margin improved✗ Asset turnover improved

Analysts

No analyst targets available.

Annual history

FYRevenueNet incomeFree cash flow
2025$610.3M$44.1M$56.8M
2024$567.6M$36.1M$26.1M
2023$482.5M$38.6M$66.5M
2022$457.8M$5.8M$41.9M
2021$427.3M$12.7M$37.3M
2020$404.6M$38.5M$40.7M

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +10.1%.

For information only · Important disclosures

Grades vs sector

No sector grades for CDRE yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Systematic Models

Held by 1 of 7 live models: SURVYR. Barbell Momentum & T-Bill Shield.

SURVYR. Barbell Momentum & T-Bill Shield
5.0% of the book · Mid-Cap RS & EPS Leaders (75%) sleeve · ranked 14 of 160
 HeldQuality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book
Why it's in the SURVYR. Barbell Momentum & T-Bill Shield #14 of 160

Qualified on +29% 6M RS, recurring duty gear + nuclear safety M&A compounding. Ranked 14th of 160 at the 2026-10-01 rebalance.

What would knock it out: Drops out if it falls outside the top 16 at the next rebalance (Oct 30).

Earnings & events

CDRE earningsNext report in 7 days
Next report · quarter Sep 2026
Wed Nov 4, 2026After the close
EPS consensus$0.34
Revenue consensus–
Last 4 quarters · EPS vs estimate
Aug 5, 2026$0.48est $0.32+50.9%Above estimates
May 11, 2026$0.18est $0.09+98.7%Above estimates
Mar 10, 2026$0.29est $0.47−37.4%Below estimates
Nov 4, 2025$0.38est $0.28+37.0%Above estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · report time: Nasdaq earnings calendar · refreshed 2026-10-24 19:17:39 ET
24-1125-0325-0525-0825-1126-0326-0526-080.000.51
EstimateActual (beat)Actual (miss)

Quarterly revenue

QuarterRevenueYoY
2026-06-30$207.1M+31.8%
2026-03-31$155.4M–
2025-12-31$167.2M–
2025-09-30$155.9M–
2025-06-30$157.1M–

Recent dividends

2026-07-31: $0.100 · 2026-05-01: $0.100 · 2026-01-30: $0.100 · 2025-10-31: $0.095 · 2025-08-01: $0.095 · 2025-05-02: $0.095 · 2025-01-31: $0.095 · 2024-11-01: $0.088

News & catalysts

More news
Is Axon Stock Increasing Your Market Risk?
Trefis · 7h ago
Insider trades
Kanders Warren B
Director, CEO AND CHAIRMAN, 10% owner · 2026-08-25
Sell
$1.4M
Kanders Warren B
Director, CEO AND CHAIRMAN, 10% owner · 2026-08-25
Sell
$1.7M
Kanders Warren B
Director, CEO AND CHAIRMAN, 10% owner · 2026-08-24
Sell
$1.2M
Kanders Warren B
Director, CEO AND CHAIRMAN, 10% owner · 2026-08-24
Sell
$2.2M
Williams Brad
PRESIDENT · 2026-08-17
Sell
$2.9M
Williams Brad
PRESIDENT · 2026-08-17
Sell
$3.6K

Stats refreshed 2026-10-24 19:17:39 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026